| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Epithelial Cells | 39 | 2025 | 1063 | 7.280 |
Why?
|
| Respiratory Mucosa | 27 | 2025 | 307 | 6.330 |
Why?
|
| Pneumonia, Mycoplasma | 20 | 2020 | 56 | 4.930 |
Why?
|
| Interleukin-13 | 18 | 2025 | 147 | 4.520 |
Why?
|
| Rhinovirus | 10 | 2024 | 56 | 4.450 |
Why?
|
| Mycoplasma pneumoniae | 22 | 2020 | 56 | 4.330 |
Why?
|
| Picornaviridae Infections | 9 | 2024 | 45 | 4.250 |
Why?
|
| Influenza A virus | 5 | 2025 | 100 | 3.970 |
Why?
|
| Electronic Nicotine Delivery Systems | 6 | 2023 | 89 | 3.970 |
Why?
|
| Lung | 49 | 2025 | 3927 | 3.800 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 9 | 2025 | 442 | 3.640 |
Why?
|
| Asthma | 35 | 2024 | 2229 | 3.590 |
Why?
|
| Glycoproteins | 11 | 2019 | 338 | 3.050 |
Why?
|
| Phosphoproteins | 11 | 2019 | 332 | 2.980 |
Why?
|
| Immunity, Innate | 19 | 2022 | 803 | 2.780 |
Why?
|
| Toll-Like Receptor 2 | 13 | 2018 | 113 | 2.740 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 15 | 2025 | 983 | 2.640 |
Why?
|
| Inflammation | 26 | 2025 | 2737 | 2.550 |
Why?
|
| Interleukin-1 Receptor-Associated Kinases | 7 | 2019 | 27 | 2.410 |
Why?
|
| Proteasome Endopeptidase Complex | 3 | 2025 | 148 | 2.330 |
Why?
|
| Mice, Knockout | 24 | 2025 | 2871 | 2.300 |
Why?
|
| Influenza, Human | 5 | 2025 | 601 | 2.280 |
Why?
|
| Vaping | 3 | 2023 | 54 | 2.230 |
Why?
|
| Respiratory System | 9 | 2019 | 154 | 2.080 |
Why?
|
| Bronchi | 12 | 2017 | 247 | 2.050 |
Why?
|
| Cells, Cultured | 35 | 2025 | 4077 | 2.010 |
Why?
|
| Smoking | 15 | 2022 | 1499 | 1.960 |
Why?
|
| Orthomyxoviridae Infections | 3 | 2024 | 67 | 1.770 |
Why?
|
| Virus Diseases | 3 | 2023 | 210 | 1.740 |
Why?
|
| Neutrophils | 14 | 2023 | 1207 | 1.730 |
Why?
|
| Pneumonia | 6 | 2023 | 616 | 1.730 |
Why?
|
| Particulate Matter | 5 | 2022 | 246 | 1.640 |
Why?
|
| Mice | 64 | 2025 | 16915 | 1.570 |
Why?
|
| Cigarette Smoking | 3 | 2025 | 91 | 1.560 |
Why?
|
| Bacterial Infections | 4 | 2020 | 235 | 1.530 |
Why?
|
| Mice, Inbred C57BL | 27 | 2025 | 5439 | 1.490 |
Why?
|
| Pulmonary Surfactant-Associated Protein A | 5 | 2024 | 35 | 1.460 |
Why?
|
| Growth Differentiation Factor 15 | 3 | 2017 | 41 | 1.450 |
Why?
|
| alpha 1-Antitrypsin | 4 | 2017 | 107 | 1.440 |
Why?
|
| Pseudomonas aeruginosa | 6 | 2016 | 347 | 1.440 |
Why?
|
| Pseudomonas Infections | 5 | 2016 | 221 | 1.430 |
Why?
|
| Lung Injury | 2 | 2023 | 210 | 1.370 |
Why?
|
| DNA, Mitochondrial | 2 | 2023 | 191 | 1.350 |
Why?
|
| Cytokines | 17 | 2024 | 2013 | 1.310 |
Why?
|
| Smoke | 9 | 2022 | 139 | 1.280 |
Why?
|
| Animals | 71 | 2025 | 35309 | 1.280 |
Why?
|
| Macrophages, Alveolar | 7 | 2018 | 389 | 1.260 |
Why?
|
| Lung Diseases | 5 | 2021 | 739 | 1.250 |
Why?
|
| Antiviral Agents | 7 | 2023 | 712 | 1.230 |
Why?
|
| Respiratory Hypersensitivity | 3 | 2025 | 64 | 1.230 |
Why?
|
| Interleukin-1 Receptor-Like 1 Protein | 4 | 2023 | 26 | 1.170 |
Why?
|
| Enterovirus Infections | 2 | 2022 | 171 | 1.170 |
Why?
|
| Mice, Inbred BALB C | 20 | 2022 | 1247 | 1.130 |
Why?
|
| Signal Transduction | 22 | 2025 | 4926 | 1.080 |
Why?
|
| Bronchoalveolar Lavage Fluid | 21 | 2021 | 644 | 1.070 |
Why?
|
| Host-Pathogen Interactions | 5 | 2018 | 351 | 1.050 |
Why?
|
| Up-Regulation | 9 | 2020 | 839 | 0.980 |
Why?
|
| CD146 Antigen | 5 | 2017 | 41 | 0.970 |
Why?
|
| Humans | 97 | 2025 | 129266 | 0.960 |
Why?
|
| Interleukin-4 Receptor alpha Subunit | 1 | 2025 | 8 | 0.960 |
Why?
|
| Alveolar Epithelial Cells | 4 | 2022 | 106 | 0.950 |
Why?
|
| Interleukin-33 | 7 | 2023 | 48 | 0.940 |
Why?
|
| Anti-Inflammatory Agents | 5 | 2022 | 480 | 0.930 |
Why?
|
| Toll-Like Receptor 3 | 1 | 2024 | 27 | 0.920 |
Why?
|
| Th2 Cells | 5 | 2019 | 171 | 0.910 |
Why?
|
| Poly I-C | 1 | 2024 | 62 | 0.910 |
Why?
|
| Receptors, Cell Surface | 3 | 2025 | 380 | 0.910 |
Why?
|
| Receptors, Purinergic P2 | 1 | 2023 | 23 | 0.870 |
Why?
|
| Virus Replication | 3 | 2017 | 450 | 0.860 |
Why?
|
| Autophagy | 3 | 2015 | 266 | 0.850 |
Why?
|
| Eosinophils | 7 | 2024 | 324 | 0.840 |
Why?
|
| Mitochondrial Diseases | 1 | 2024 | 90 | 0.830 |
Why?
|
| Inflammation Mediators | 4 | 2018 | 505 | 0.810 |
Why?
|
| Gene Expression Regulation | 13 | 2025 | 2537 | 0.800 |
Why?
|
| Single-Cell Analysis | 1 | 2025 | 275 | 0.790 |
Why?
|
| Neurodegenerative Diseases | 1 | 2024 | 112 | 0.780 |
Why?
|
| Disease Models, Animal | 16 | 2024 | 4057 | 0.750 |
Why?
|
| Organoids | 1 | 2022 | 104 | 0.740 |
Why?
|
| Integrin alpha4beta1 | 1 | 2021 | 7 | 0.740 |
Why?
|
| Bronchioles | 1 | 2021 | 23 | 0.730 |
Why?
|
| RNA, Messenger | 12 | 2021 | 2703 | 0.730 |
Why?
|
| Allergens | 6 | 2023 | 385 | 0.700 |
Why?
|
| Trachea | 3 | 2017 | 220 | 0.680 |
Why?
|
| Transforming Growth Factor beta | 5 | 2011 | 455 | 0.680 |
Why?
|
| STAT3 Transcription Factor | 1 | 2022 | 194 | 0.670 |
Why?
|
| Immune Evasion | 1 | 2020 | 56 | 0.660 |
Why?
|
| Enterovirus | 2 | 2024 | 78 | 0.660 |
Why?
|
| CRISPR-Cas Systems | 2 | 2018 | 108 | 0.650 |
Why?
|
| Chemokine CCL11 | 2 | 2018 | 26 | 0.640 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2020 | 154 | 0.620 |
Why?
|
| Macrophages | 9 | 2020 | 1484 | 0.600 |
Why?
|
| Down-Regulation | 5 | 2025 | 636 | 0.590 |
Why?
|
| Pulmonary Eosinophilia | 1 | 2018 | 27 | 0.570 |
Why?
|
| NF-kappa B | 6 | 2012 | 665 | 0.570 |
Why?
|
| Tumor Necrosis Factor-alpha | 7 | 2025 | 1202 | 0.560 |
Why?
|
| Leukocyte Elastase | 3 | 2017 | 74 | 0.550 |
Why?
|
| Gene Editing | 1 | 2018 | 67 | 0.550 |
Why?
|
| Cell Adhesion Molecules | 1 | 2018 | 173 | 0.540 |
Why?
|
| Interferons | 2 | 2015 | 193 | 0.520 |
Why?
|
| Mucins | 3 | 2006 | 70 | 0.520 |
Why?
|
| RNA, Small Interfering | 6 | 2019 | 591 | 0.520 |
Why?
|
| Receptors, Immunologic | 3 | 2008 | 216 | 0.500 |
Why?
|
| Middle Aged | 25 | 2025 | 31090 | 0.500 |
Why?
|
| Epithelial Sodium Channels | 1 | 2015 | 19 | 0.500 |
Why?
|
| Cell Culture Techniques | 1 | 2018 | 336 | 0.490 |
Why?
|
| Afghanistan | 5 | 2022 | 70 | 0.480 |
Why?
|
| Trehalose | 1 | 2015 | 30 | 0.480 |
Why?
|
| Interleukin-8 | 7 | 2019 | 262 | 0.470 |
Why?
|
| Lipoproteins | 3 | 2011 | 171 | 0.470 |
Why?
|
| Cellular Senescence | 1 | 2016 | 181 | 0.460 |
Why?
|
| Respiratory Tract Infections | 2 | 2016 | 375 | 0.460 |
Why?
|
| Primary Cell Culture | 3 | 2020 | 160 | 0.450 |
Why?
|
| Gene Knockdown Techniques | 4 | 2025 | 316 | 0.450 |
Why?
|
| Pyroglyphidae | 2 | 2024 | 17 | 0.450 |
Why?
|
| Female | 40 | 2025 | 68551 | 0.440 |
Why?
|
| Androstadienes | 3 | 2010 | 106 | 0.440 |
Why?
|
| Bronchial Hyperreactivity | 3 | 2015 | 105 | 0.440 |
Why?
|
| Bacteria | 1 | 2020 | 813 | 0.430 |
Why?
|
| Viral Load | 3 | 2024 | 448 | 0.420 |
Why?
|
| Neutrophil Infiltration | 2 | 2013 | 105 | 0.420 |
Why?
|
| Recombinant Proteins | 5 | 2019 | 1304 | 0.410 |
Why?
|
| Haemophilus Infections | 1 | 2013 | 39 | 0.410 |
Why?
|
| Dinoprostone | 2 | 2011 | 187 | 0.400 |
Why?
|
| Transcription Factors | 5 | 2025 | 1647 | 0.400 |
Why?
|
| Mucociliary Clearance | 1 | 2012 | 42 | 0.400 |
Why?
|
| Cell Line | 10 | 2020 | 2779 | 0.400 |
Why?
|
| Mucin 5AC | 4 | 2024 | 69 | 0.400 |
Why?
|
| Proteasome Inhibitors | 2 | 2025 | 42 | 0.390 |
Why?
|
| Male | 34 | 2025 | 63512 | 0.380 |
Why?
|
| Mice, Transgenic | 6 | 2022 | 2117 | 0.370 |
Why?
|
| Moraxellaceae Infections | 1 | 2011 | 3 | 0.370 |
Why?
|
| Transcription Factor AP-1 | 1 | 2011 | 88 | 0.360 |
Why?
|
| Epithelium | 3 | 2022 | 311 | 0.360 |
Why?
|
| Mitogen-Activated Protein Kinases | 2 | 2011 | 311 | 0.350 |
Why?
|
| Hypersensitivity | 3 | 2024 | 248 | 0.350 |
Why?
|
| Adrenergic Agonists | 1 | 2010 | 5 | 0.350 |
Why?
|
| Adenosine Triphosphate | 2 | 2023 | 478 | 0.340 |
Why?
|
| Adrenergic beta-2 Receptor Agonists | 1 | 2010 | 35 | 0.340 |
Why?
|
| Healthy Volunteers | 2 | 2022 | 200 | 0.330 |
Why?
|
| Proteolysis | 2 | 2025 | 167 | 0.320 |
Why?
|
| Interferon-beta | 2 | 2024 | 89 | 0.320 |
Why?
|
| Aged | 13 | 2022 | 22032 | 0.320 |
Why?
|
| Genetic Predisposition to Disease | 4 | 2021 | 2276 | 0.300 |
Why?
|
| Adult | 21 | 2022 | 35495 | 0.290 |
Why?
|
| Interleukins | 3 | 2015 | 241 | 0.290 |
Why?
|
| Anti-Bacterial Agents | 2 | 2015 | 1708 | 0.280 |
Why?
|
| Models, Animal | 1 | 2009 | 376 | 0.280 |
Why?
|
| Wound Healing | 2 | 2016 | 306 | 0.280 |
Why?
|
| Phosphatidylglycerols | 3 | 2019 | 24 | 0.280 |
Why?
|
| Mast Cells | 2 | 2025 | 142 | 0.270 |
Why?
|
| Interleukin-23 | 1 | 2006 | 19 | 0.270 |
Why?
|
| Bronchoalveolar Lavage | 4 | 2021 | 92 | 0.260 |
Why?
|
| Mycoplasma Infections | 1 | 2006 | 15 | 0.260 |
Why?
|
| Interleukin-17 | 1 | 2006 | 108 | 0.260 |
Why?
|
| Lipopolysaccharides | 4 | 2015 | 877 | 0.260 |
Why?
|
| Leukocyte Count | 4 | 2020 | 326 | 0.250 |
Why?
|
| Caenorhabditis elegans | 1 | 2009 | 290 | 0.250 |
Why?
|
| Matrix Metalloproteinase 9 | 2 | 2003 | 119 | 0.250 |
Why?
|
| Ovalbumin | 4 | 2017 | 178 | 0.250 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2015 | 947 | 0.250 |
Why?
|
| Fibroblasts | 4 | 2021 | 948 | 0.250 |
Why?
|
| NF-E2-Related Factor 2 | 3 | 2016 | 79 | 0.250 |
Why?
|
| Glutathione | 3 | 2015 | 347 | 0.250 |
Why?
|
| Chemokine CCL24 | 2 | 2018 | 11 | 0.250 |
Why?
|
| Bacterial Load | 4 | 2013 | 66 | 0.240 |
Why?
|
| Sequence Analysis, RNA | 2 | 2025 | 428 | 0.240 |
Why?
|
| Enhancer of Zeste Homolog 2 Protein | 1 | 2025 | 41 | 0.240 |
Why?
|
| MicroRNAs | 1 | 2011 | 676 | 0.230 |
Why?
|
| Lysosomes | 2 | 2016 | 137 | 0.230 |
Why?
|
| Interleukin-4 | 4 | 2013 | 212 | 0.230 |
Why?
|
| Body Fluids | 2 | 2023 | 63 | 0.230 |
Why?
|
| Oxidative Stress | 5 | 2024 | 1266 | 0.230 |
Why?
|
| Respiratory Tract Diseases | 2 | 2022 | 148 | 0.230 |
Why?
|
| Case-Control Studies | 5 | 2020 | 3377 | 0.220 |
Why?
|
| Toll-Like Receptors | 3 | 2020 | 179 | 0.220 |
Why?
|
| DNA-Binding Proteins | 1 | 2011 | 1446 | 0.220 |
Why?
|
| Dermatophagoides pteronyssinus | 1 | 2023 | 3 | 0.220 |
Why?
|
| Lectins | 1 | 2024 | 48 | 0.220 |
Why?
|
| GPI-Linked Proteins | 1 | 2024 | 68 | 0.220 |
Why?
|
| Mucus | 1 | 2024 | 77 | 0.210 |
Why?
|
| Adenoviridae | 3 | 2016 | 192 | 0.210 |
Why?
|
| Phosphorylation | 3 | 2016 | 1710 | 0.210 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2025 | 201 | 0.210 |
Why?
|
| Bronchoconstriction | 1 | 2003 | 32 | 0.210 |
Why?
|
| Hygiene | 1 | 2003 | 29 | 0.210 |
Why?
|
| Chemotactic Factors, Eosinophil | 1 | 2002 | 7 | 0.200 |
Why?
|
| Epigenesis, Genetic | 2 | 2025 | 616 | 0.200 |
Why?
|
| Toll-Like Receptor 9 | 1 | 2023 | 31 | 0.200 |
Why?
|
| Nasal Mucosa | 2 | 2024 | 107 | 0.200 |
Why?
|
| Cell Differentiation | 3 | 2025 | 1887 | 0.200 |
Why?
|
| Chemokine CCL26 | 2 | 2019 | 9 | 0.200 |
Why?
|
| Chemokines, CC | 1 | 2002 | 33 | 0.200 |
Why?
|
| Collagen | 1 | 2005 | 433 | 0.200 |
Why?
|
| Tobacco Smoking | 1 | 2022 | 25 | 0.200 |
Why?
|
| Forced Expiratory Volume | 3 | 2019 | 510 | 0.200 |
Why?
|
| Apyrase | 1 | 2022 | 16 | 0.200 |
Why?
|
| Adolescent | 6 | 2023 | 20313 | 0.200 |
Why?
|
| STAT6 Transcription Factor | 2 | 2018 | 26 | 0.200 |
Why?
|
| Airway Remodeling | 2 | 2020 | 61 | 0.190 |
Why?
|
| Interleukin-6 | 4 | 2016 | 720 | 0.190 |
Why?
|
| Iraq | 1 | 2021 | 52 | 0.190 |
Why?
|
| Blotting, Western | 3 | 2015 | 1204 | 0.190 |
Why?
|
| Respiratory Syncytial Viruses | 2 | 2013 | 52 | 0.180 |
Why?
|
| Bronchodilator Agents | 1 | 2003 | 243 | 0.180 |
Why?
|
| Adoptive Transfer | 2 | 2019 | 218 | 0.180 |
Why?
|
| Adjuvants, Immunologic | 1 | 2002 | 221 | 0.180 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 4 | 2015 | 833 | 0.180 |
Why?
|
| Polymerase Chain Reaction | 5 | 2011 | 1036 | 0.180 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2022 | 509 | 0.180 |
Why?
|
| Reactive Oxygen Species | 1 | 2024 | 596 | 0.180 |
Why?
|
| beta-Defensins | 2 | 2011 | 20 | 0.180 |
Why?
|
| Dronabinol | 1 | 2023 | 203 | 0.180 |
Why?
|
| Gene Transfer Techniques | 2 | 2012 | 161 | 0.170 |
Why?
|
| Receptors, Androgen | 1 | 2022 | 147 | 0.170 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2019 | 2063 | 0.170 |
Why?
|
| Antibodies, Neutralizing | 1 | 2023 | 265 | 0.170 |
Why?
|
| Obesity | 2 | 2024 | 2879 | 0.170 |
Why?
|
| Phosphatidylinositols | 1 | 2019 | 57 | 0.160 |
Why?
|
| Phosphatidylinositol 3-Kinases | 2 | 2011 | 360 | 0.160 |
Why?
|
| Cell Separation | 2 | 2018 | 316 | 0.160 |
Why?
|
| Turbinates | 1 | 2019 | 16 | 0.160 |
Why?
|
| Arachidonate 15-Lipoxygenase | 1 | 2019 | 23 | 0.160 |
Why?
|
| Wnt Proteins | 1 | 2020 | 127 | 0.160 |
Why?
|
| Cytoprotection | 2 | 2016 | 56 | 0.160 |
Why?
|
| RNA Interference | 3 | 2013 | 450 | 0.160 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2022 | 373 | 0.150 |
Why?
|
| Cell Proliferation | 2 | 2018 | 2375 | 0.150 |
Why?
|
| Neutrophil Activation | 1 | 2019 | 79 | 0.150 |
Why?
|
| Nasal Polyps | 1 | 2019 | 59 | 0.150 |
Why?
|
| Bronchial Diseases | 1 | 2018 | 37 | 0.150 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2019 | 169 | 0.150 |
Why?
|
| Wnt Signaling Pathway | 1 | 2020 | 170 | 0.150 |
Why?
|
| Cysteine Endopeptidases | 1 | 2018 | 68 | 0.150 |
Why?
|
| Neovascularization, Pathologic | 1 | 2020 | 296 | 0.150 |
Why?
|
| Immunomodulation | 1 | 2019 | 92 | 0.150 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 1 | 2019 | 146 | 0.150 |
Why?
|
| Feeder Cells | 1 | 2018 | 3 | 0.150 |
Why?
|
| INDEL Mutation | 1 | 2018 | 15 | 0.150 |
Why?
|
| Lentivirus | 1 | 2018 | 53 | 0.140 |
Why?
|
| Oncostatin M | 1 | 2017 | 6 | 0.140 |
Why?
|
| Young Adult | 4 | 2023 | 12391 | 0.140 |
Why?
|
| Lymphocytes | 3 | 2017 | 378 | 0.140 |
Why?
|
| Rhinitis | 1 | 2019 | 152 | 0.140 |
Why?
|
| Gene Knockout Techniques | 1 | 2018 | 109 | 0.140 |
Why?
|
| Monocytes | 2 | 2021 | 551 | 0.140 |
Why?
|
| Bacteriolysis | 1 | 2016 | 9 | 0.140 |
Why?
|
| Real-Time Polymerase Chain Reaction | 2 | 2015 | 328 | 0.140 |
Why?
|
| Receptors, Interleukin-1 | 1 | 2018 | 218 | 0.130 |
Why?
|
| Colony Count, Microbial | 2 | 2008 | 117 | 0.130 |
Why?
|
| Immunoenzyme Techniques | 2 | 2015 | 214 | 0.130 |
Why?
|
| Cell Movement | 2 | 2016 | 944 | 0.130 |
Why?
|
| Lymphocyte Subsets | 1 | 2017 | 84 | 0.130 |
Why?
|
| Protein Deglycase DJ-1 | 1 | 2016 | 11 | 0.130 |
Why?
|
| Smad1 Protein | 1 | 2016 | 18 | 0.130 |
Why?
|
| Cloning, Molecular | 1 | 2018 | 525 | 0.130 |
Why?
|
| Sinusitis | 1 | 2019 | 210 | 0.130 |
Why?
|
| RNA | 1 | 2023 | 880 | 0.130 |
Why?
|
| Activin Receptors, Type II | 1 | 2016 | 11 | 0.130 |
Why?
|
| Hesperidin | 1 | 2016 | 1 | 0.130 |
Why?
|
| Ileus | 1 | 2016 | 12 | 0.130 |
Why?
|
| Oligopeptides | 1 | 2018 | 258 | 0.130 |
Why?
|
| Drug Resistance | 1 | 2017 | 166 | 0.130 |
Why?
|
| Mitochondria | 1 | 2023 | 877 | 0.130 |
Why?
|
| Peroxidase | 1 | 2016 | 174 | 0.130 |
Why?
|
| Cell Membrane Permeability | 1 | 2016 | 82 | 0.130 |
Why?
|
| Fluticasone | 3 | 2010 | 90 | 0.130 |
Why?
|
| Alleles | 1 | 2019 | 845 | 0.130 |
Why?
|
| Dose-Response Relationship, Immunologic | 3 | 2006 | 82 | 0.130 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2016 | 135 | 0.120 |
Why?
|
| Homeostasis | 2 | 2010 | 605 | 0.120 |
Why?
|
| Myosins | 1 | 2016 | 133 | 0.120 |
Why?
|
| HEK293 Cells | 3 | 2014 | 696 | 0.120 |
Why?
|
| Pulmonary Emphysema | 2 | 2020 | 275 | 0.120 |
Why?
|
| Immunohistochemistry | 5 | 2010 | 1691 | 0.120 |
Why?
|
| Acetylcysteine | 2 | 2013 | 146 | 0.120 |
Why?
|
| Superoxide Dismutase | 1 | 2017 | 342 | 0.120 |
Why?
|
| Military Personnel | 1 | 2021 | 515 | 0.120 |
Why?
|
| Antibodies, Blocking | 1 | 2015 | 33 | 0.120 |
Why?
|
| Peptides | 1 | 2020 | 923 | 0.120 |
Why?
|
| Pulmonary Surfactants | 2 | 2019 | 106 | 0.120 |
Why?
|
| Cell Polarity | 1 | 2016 | 139 | 0.120 |
Why?
|
| Immunoprecipitation | 1 | 2015 | 157 | 0.120 |
Why?
|
| Severity of Illness Index | 3 | 2019 | 2740 | 0.120 |
Why?
|
| Enzyme Activation | 2 | 2019 | 812 | 0.120 |
Why?
|
| Promoter Regions, Genetic | 2 | 2011 | 1204 | 0.120 |
Why?
|
| Pulmonary Alveoli | 2 | 2020 | 400 | 0.110 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 2013 | 1056 | 0.110 |
Why?
|
| Idiopathic Pulmonary Fibrosis | 1 | 2021 | 633 | 0.110 |
Why?
|
| Receptor, ErbB-2 | 1 | 2016 | 326 | 0.110 |
Why?
|
| Endothelium, Vascular | 1 | 2020 | 901 | 0.110 |
Why?
|
| Matrix Metalloproteinases | 2 | 2015 | 90 | 0.110 |
Why?
|
| Adipose Tissue | 1 | 2017 | 590 | 0.110 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2016 | 338 | 0.100 |
Why?
|
| Free Radical Scavengers | 1 | 2013 | 82 | 0.100 |
Why?
|
| Transforming Growth Factor beta1 | 2 | 2005 | 157 | 0.100 |
Why?
|
| Haemophilus influenzae | 1 | 2013 | 63 | 0.100 |
Why?
|
| Doxycycline | 1 | 2012 | 59 | 0.100 |
Why?
|
| Respiratory Function Tests | 5 | 2017 | 583 | 0.100 |
Why?
|
| Protein Binding | 2 | 2016 | 2120 | 0.100 |
Why?
|
| Fatty Acid-Binding Proteins | 1 | 2013 | 68 | 0.100 |
Why?
|
| Respiratory Syncytial Virus Infections | 2 | 2013 | 120 | 0.100 |
Why?
|
| Nanostructures | 1 | 2013 | 100 | 0.100 |
Why?
|
| Colorectal Neoplasms | 1 | 2019 | 752 | 0.100 |
Why?
|
| Heat Shock Transcription Factors | 1 | 2011 | 19 | 0.100 |
Why?
|
| Membrane Glycoproteins | 2 | 2005 | 476 | 0.090 |
Why?
|
| Lipopeptides | 1 | 2011 | 13 | 0.090 |
Why?
|
| HeLa Cells | 1 | 2013 | 611 | 0.090 |
Why?
|
| Administration, Inhalation | 2 | 2004 | 666 | 0.090 |
Why?
|
| Interferon-gamma | 2 | 2006 | 772 | 0.090 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2011 | 69 | 0.090 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2011 | 161 | 0.090 |
Why?
|
| Cell Line, Tumor | 2 | 2011 | 3202 | 0.090 |
Why?
|
| Lactoferrin | 1 | 2011 | 28 | 0.090 |
Why?
|
| Immunity, Mucosal | 1 | 2011 | 94 | 0.090 |
Why?
|
| Clarithromycin | 1 | 2010 | 28 | 0.090 |
Why?
|
| Lipids | 1 | 2014 | 625 | 0.090 |
Why?
|
| Gene Expression | 3 | 2022 | 1466 | 0.090 |
Why?
|
| Formoterol Fumarate | 1 | 2010 | 7 | 0.090 |
Why?
|
| Ethanolamines | 1 | 2010 | 17 | 0.090 |
Why?
|
| Bacterial Adhesion | 1 | 2011 | 91 | 0.080 |
Why?
|
| Virus Attachment | 2 | 2024 | 16 | 0.080 |
Why?
|
| Receptors, Adrenergic, beta-2 | 1 | 2010 | 46 | 0.080 |
Why?
|
| Integrin alpha5beta1 | 1 | 2010 | 10 | 0.080 |
Why?
|
| Drug Delivery Systems | 1 | 2013 | 333 | 0.080 |
Why?
|
| Albuterol | 1 | 2010 | 103 | 0.080 |
Why?
|
| Transcriptional Activation | 1 | 2011 | 367 | 0.080 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2010 | 63 | 0.080 |
Why?
|
| Uteroglobin | 1 | 2009 | 23 | 0.080 |
Why?
|
| Immunity | 1 | 2010 | 138 | 0.080 |
Why?
|
| Cotinine | 1 | 2009 | 75 | 0.080 |
Why?
|
| Recurrence | 2 | 2017 | 1005 | 0.080 |
Why?
|
| Phosphodiesterase Inhibitors | 1 | 2009 | 89 | 0.080 |
Why?
|
| Lipopolysaccharide Receptors | 2 | 2009 | 86 | 0.080 |
Why?
|
| Aminopyridines | 1 | 2009 | 97 | 0.080 |
Why?
|
| Base Sequence | 2 | 2014 | 2146 | 0.080 |
Why?
|
| Benzamides | 1 | 2009 | 207 | 0.070 |
Why?
|
| Child | 4 | 2024 | 20785 | 0.070 |
Why?
|
| Endothelial Cells | 1 | 2013 | 746 | 0.070 |
Why?
|
| Chemokines, CXC | 2 | 2004 | 70 | 0.070 |
Why?
|
| Apoptosis | 4 | 2016 | 2499 | 0.070 |
Why?
|
| Interleukin-23 Subunit p19 | 1 | 2006 | 6 | 0.070 |
Why?
|
| Interleukin-12 Subunit p40 | 1 | 2006 | 9 | 0.070 |
Why?
|
| Nicotine | 1 | 2009 | 302 | 0.070 |
Why?
|
| Phenotype | 3 | 2017 | 3074 | 0.060 |
Why?
|
| Histocytochemistry | 1 | 2006 | 82 | 0.060 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2010 | 635 | 0.060 |
Why?
|
| Lung Volume Measurements | 1 | 2006 | 45 | 0.060 |
Why?
|
| United States | 1 | 2023 | 13826 | 0.060 |
Why?
|
| Disease Susceptibility | 1 | 2008 | 333 | 0.060 |
Why?
|
| Antigens, Bacterial | 1 | 2006 | 119 | 0.060 |
Why?
|
| ErbB Receptors | 2 | 2021 | 605 | 0.060 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2011 | 1344 | 0.060 |
Why?
|
| Immune Sera | 1 | 2005 | 87 | 0.060 |
Why?
|
| Transcription, Genetic | 1 | 2011 | 1416 | 0.060 |
Why?
|
| T-Lymphocytes | 2 | 2019 | 1933 | 0.060 |
Why?
|
| Immunoglobulin M | 1 | 2006 | 276 | 0.060 |
Why?
|
| Immunoglobulin A | 1 | 2006 | 200 | 0.060 |
Why?
|
| Serine Endopeptidases | 1 | 2004 | 118 | 0.060 |
Why?
|
| Biopsy | 2 | 2004 | 1092 | 0.050 |
Why?
|
| Basement Membrane | 1 | 2003 | 31 | 0.050 |
Why?
|
| Toll-Like Receptor 4 | 3 | 2013 | 263 | 0.050 |
Why?
|
| Bronchoscopy | 2 | 2017 | 216 | 0.050 |
Why?
|
| Receptor, Platelet-Derived Growth Factor beta | 1 | 2003 | 29 | 0.050 |
Why?
|
| Dactinomycin | 1 | 2002 | 28 | 0.050 |
Why?
|
| Cycloheximide | 1 | 2002 | 56 | 0.050 |
Why?
|
| Age Factors | 3 | 2017 | 3140 | 0.050 |
Why?
|
| Research Support as Topic | 1 | 2003 | 111 | 0.050 |
Why?
|
| Molecular Sequence Data | 1 | 2007 | 2835 | 0.050 |
Why?
|
| Elastin | 1 | 2003 | 77 | 0.050 |
Why?
|
| Transposases | 1 | 2022 | 16 | 0.050 |
Why?
|
| Blotting, Northern | 1 | 2002 | 201 | 0.050 |
Why?
|
| Specimen Handling | 1 | 2023 | 162 | 0.050 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2021 | 399 | 0.050 |
Why?
|
| Eosinophilia | 1 | 2005 | 204 | 0.050 |
Why?
|
| Drug Industry | 1 | 2003 | 106 | 0.050 |
Why?
|
| Fibrosis | 1 | 2005 | 520 | 0.050 |
Why?
|
| Saliva | 1 | 2023 | 210 | 0.050 |
Why?
|
| Wood | 1 | 2022 | 15 | 0.050 |
Why?
|
| Data Interpretation, Statistical | 1 | 2003 | 336 | 0.050 |
Why?
|
| Antiporters | 1 | 2022 | 22 | 0.050 |
Why?
|
| Immunoglobulin G | 1 | 2006 | 848 | 0.050 |
Why?
|
| Interleukin-15 | 1 | 2002 | 82 | 0.050 |
Why?
|
| Tyrphostins | 1 | 2021 | 17 | 0.050 |
Why?
|
| Drug Synergism | 1 | 2002 | 370 | 0.050 |
Why?
|
| Amphiregulin | 1 | 2021 | 24 | 0.050 |
Why?
|
| Nitric Oxide Synthase | 1 | 2002 | 237 | 0.050 |
Why?
|
| Tyrosine | 1 | 2002 | 223 | 0.050 |
Why?
|
| Biophysical Phenomena | 1 | 2021 | 64 | 0.050 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2002 | 147 | 0.050 |
Why?
|
| Peptidyl-Dipeptidase A | 1 | 2021 | 52 | 0.050 |
Why?
|
| Tuberculosis, Pulmonary | 1 | 2002 | 135 | 0.050 |
Why?
|
| Keratin-5 | 1 | 2021 | 50 | 0.050 |
Why?
|
| Chronic Disease | 2 | 2019 | 1716 | 0.050 |
Why?
|
| Polymorphism, Genetic | 1 | 2024 | 639 | 0.040 |
Why?
|
| Escherichia coli | 1 | 2005 | 766 | 0.040 |
Why?
|
| Nitric Oxide Synthase Type II | 2 | 2016 | 171 | 0.040 |
Why?
|
| RAW 264.7 Cells | 1 | 2020 | 49 | 0.040 |
Why?
|
| Biomarkers | 3 | 2017 | 3968 | 0.040 |
Why?
|
| Adhesins, Bacterial | 1 | 2020 | 40 | 0.040 |
Why?
|
| Ligands | 2 | 2014 | 621 | 0.040 |
Why?
|
| Transcription Factor RelA | 1 | 2020 | 83 | 0.040 |
Why?
|
| Madin Darby Canine Kidney Cells | 1 | 2019 | 14 | 0.040 |
Why?
|
| Aging | 1 | 2010 | 1774 | 0.040 |
Why?
|
| Transfection | 2 | 2013 | 915 | 0.040 |
Why?
|
| Trans-Activators | 1 | 2002 | 388 | 0.040 |
Why?
|
| Quinazolines | 1 | 2021 | 244 | 0.040 |
Why?
|
| Azoxymethane | 1 | 2019 | 19 | 0.040 |
Why?
|
| CD11 Antigens | 1 | 2019 | 30 | 0.040 |
Why?
|
| B7-1 Antigen | 1 | 2019 | 61 | 0.040 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2020 | 275 | 0.040 |
Why?
|
| Vascular System Injuries | 1 | 2020 | 73 | 0.040 |
Why?
|
| Mucin-5B | 1 | 2021 | 214 | 0.040 |
Why?
|
| Particle Size | 1 | 2020 | 352 | 0.040 |
Why?
|
| Bacterial Proteins | 1 | 2005 | 833 | 0.040 |
Why?
|
| Protein Domains | 1 | 2020 | 253 | 0.040 |
Why?
|
| CD40 Antigens | 1 | 2019 | 88 | 0.040 |
Why?
|
| Chromatin | 1 | 2022 | 478 | 0.040 |
Why?
|
| Dogs | 1 | 2019 | 382 | 0.040 |
Why?
|
| beta Catenin | 1 | 2020 | 223 | 0.040 |
Why?
|
| Gene Expression Profiling | 1 | 2004 | 1688 | 0.040 |
Why?
|
| Porphyrins | 1 | 2017 | 21 | 0.040 |
Why?
|
| B7-H1 Antigen | 1 | 2019 | 195 | 0.030 |
Why?
|
| Research Design | 1 | 2003 | 1043 | 0.030 |
Why?
|
| Genomics | 1 | 2022 | 717 | 0.030 |
Why?
|
| Stromal Cells | 1 | 2017 | 105 | 0.030 |
Why?
|
| Colitis | 1 | 2019 | 241 | 0.030 |
Why?
|
| Myosin-Light-Chain Kinase | 1 | 2016 | 20 | 0.030 |
Why?
|
| Cecum | 1 | 2016 | 32 | 0.030 |
Why?
|
| Verapamil | 1 | 2016 | 41 | 0.030 |
Why?
|
| Myosin Light Chains | 1 | 2016 | 27 | 0.030 |
Why?
|
| Gastrointestinal Motility | 1 | 2016 | 26 | 0.030 |
Why?
|
| Gastric Emptying | 1 | 2016 | 39 | 0.030 |
Why?
|
| Steroids | 1 | 2017 | 158 | 0.030 |
Why?
|
| Cell Count | 1 | 2017 | 311 | 0.030 |
Why?
|
| Rats | 2 | 2016 | 5482 | 0.030 |
Why?
|
| Receptor, ErbB-3 | 1 | 2016 | 44 | 0.030 |
Why?
|
| Neuregulin-1 | 1 | 2016 | 46 | 0.030 |
Why?
|
| Naphthalenes | 1 | 2016 | 57 | 0.030 |
Why?
|
| Electric Impedance | 1 | 2016 | 102 | 0.030 |
Why?
|
| Azepines | 1 | 2016 | 88 | 0.030 |
Why?
|
| Immunophenotyping | 1 | 2017 | 310 | 0.030 |
Why?
|
| Cyclooxygenase 2 | 1 | 2016 | 177 | 0.030 |
Why?
|
| Aldehydes | 1 | 2016 | 142 | 0.030 |
Why?
|
| Sputum | 1 | 2017 | 301 | 0.030 |
Why?
|
| Lymphocyte Activation | 1 | 2019 | 1109 | 0.030 |
Why?
|
| Risk Factors | 2 | 2021 | 9745 | 0.030 |
Why?
|
| Intestine, Small | 1 | 2016 | 150 | 0.030 |
Why?
|
| Disease Progression | 2 | 2015 | 2630 | 0.030 |
Why?
|
| Feedback, Physiological | 1 | 2015 | 76 | 0.030 |
Why?
|
| Lymphocyte Depletion | 1 | 2015 | 131 | 0.030 |
Why?
|
| Mice, Inbred C3H | 2 | 2005 | 272 | 0.030 |
Why?
|
| Chemokine CCL20 | 1 | 2013 | 5 | 0.030 |
Why?
|
| Chemokine CXCL2 | 1 | 2013 | 43 | 0.030 |
Why?
|
| Endosomes | 1 | 2015 | 126 | 0.030 |
Why?
|
| Chemokine CXCL1 | 1 | 2013 | 72 | 0.030 |
Why?
|
| Suppressor of Cytokine Signaling Proteins | 1 | 2013 | 21 | 0.030 |
Why?
|
| Bone Marrow Transplantation | 1 | 2015 | 275 | 0.030 |
Why?
|
| DNA Primers | 1 | 2014 | 510 | 0.030 |
Why?
|
| Virus Cultivation | 1 | 2013 | 28 | 0.030 |
Why?
|
| Hypersensitivity, Immediate | 1 | 2013 | 43 | 0.030 |
Why?
|
| STAT1 Transcription Factor | 1 | 2013 | 70 | 0.030 |
Why?
|
| Apolipoprotein A-I | 1 | 2013 | 28 | 0.030 |
Why?
|
| Muscle Contraction | 1 | 2016 | 422 | 0.030 |
Why?
|
| Pulmonary Edema | 1 | 2013 | 106 | 0.030 |
Why?
|
| Administration, Intranasal | 1 | 2013 | 84 | 0.030 |
Why?
|
| Capillary Permeability | 1 | 2013 | 140 | 0.030 |
Why?
|
| Pandemics | 1 | 2021 | 1481 | 0.030 |
Why?
|
| Genotype | 1 | 2017 | 1835 | 0.020 |
Why?
|
| Lipid Bilayers | 1 | 2013 | 97 | 0.020 |
Why?
|
| Early Diagnosis | 1 | 2013 | 233 | 0.020 |
Why?
|
| Emphysema | 1 | 2013 | 109 | 0.020 |
Why?
|
| Propidium | 1 | 2011 | 8 | 0.020 |
Why?
|
| Chromans | 1 | 2011 | 24 | 0.020 |
Why?
|
| Interleukin-18 | 1 | 2013 | 237 | 0.020 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2011 | 124 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2016 | 2011 | 0.020 |
Why?
|
| Tobacco Products | 1 | 2013 | 110 | 0.020 |
Why?
|
| PPAR gamma | 1 | 2013 | 183 | 0.020 |
Why?
|
| Protein Conformation | 1 | 2014 | 861 | 0.020 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2011 | 113 | 0.020 |
Why?
|
| Bronchial Provocation Tests | 1 | 2011 | 51 | 0.020 |
Why?
|
| Treatment Outcome | 2 | 2019 | 10202 | 0.020 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2013 | 217 | 0.020 |
Why?
|
| Biofilms | 1 | 2013 | 243 | 0.020 |
Why?
|
| Chlamydophila pneumoniae | 1 | 2010 | 12 | 0.020 |
Why?
|
| Necrosis | 1 | 2011 | 232 | 0.020 |
Why?
|
| Benzimidazoles | 1 | 2011 | 162 | 0.020 |
Why?
|
| Tobacco Smoke Pollution | 1 | 2013 | 231 | 0.020 |
Why?
|
| Plasmids | 1 | 2011 | 358 | 0.020 |
Why?
|
| Rho Guanine Nucleotide Exchange Factors | 1 | 2010 | 22 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2013 | 1288 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 2011 | 398 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2024 | 10459 | 0.020 |
Why?
|
| Calcium | 1 | 2016 | 1212 | 0.020 |
Why?
|
| Cell Survival | 1 | 2013 | 1075 | 0.020 |
Why?
|
| Macrophages, Peritoneal | 1 | 2010 | 92 | 0.020 |
Why?
|
| Mice, Inbred Strains | 1 | 2010 | 406 | 0.020 |
Why?
|
| Mice, Inbred AKR | 1 | 2009 | 35 | 0.020 |
Why?
|
| Proliferating Cell Nuclear Antigen | 1 | 2009 | 53 | 0.020 |
Why?
|
| Fibronectins | 1 | 2010 | 123 | 0.020 |
Why?
|
| Cyclopropanes | 1 | 2009 | 89 | 0.020 |
Why?
|
| Survival Rate | 1 | 2013 | 1869 | 0.020 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2010 | 286 | 0.020 |
Why?
|
| Leukocytes | 1 | 2010 | 306 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2009 | 420 | 0.020 |
Why?
|
| Cell Death | 1 | 2009 | 354 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2013 | 1949 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2013 | 2396 | 0.020 |
Why?
|
| Cell Membrane | 1 | 2011 | 733 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2010 | 1040 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2017 | 5409 | 0.020 |
Why?
|
| Biomechanical Phenomena | 1 | 2010 | 757 | 0.020 |
Why?
|
| Adaptation, Physiological | 1 | 2010 | 513 | 0.020 |
Why?
|
| Autoantibodies | 1 | 2013 | 1467 | 0.020 |
Why?
|
| Receptors, Platelet-Derived Growth Factor | 1 | 2005 | 14 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-sis | 1 | 2005 | 35 | 0.010 |
Why?
|
| Procollagen | 1 | 2005 | 21 | 0.010 |
Why?
|
| Chymases | 1 | 2004 | 4 | 0.010 |
Why?
|
| Chemokine CXCL5 | 1 | 2004 | 11 | 0.010 |
Why?
|
| Connective Tissue | 1 | 2005 | 37 | 0.010 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 2005 | 89 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 2016 | 2473 | 0.010 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2005 | 56 | 0.010 |
Why?
|
| Antigens, Differentiation | 1 | 2004 | 81 | 0.010 |
Why?
|
| Growth Substances | 1 | 2005 | 150 | 0.010 |
Why?
|
| Oxidation-Reduction | 1 | 2008 | 1028 | 0.010 |
Why?
|
| Transforming Growth Factor beta2 | 1 | 2005 | 35 | 0.010 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2004 | 96 | 0.010 |
Why?
|
| Muscle, Smooth | 1 | 2005 | 157 | 0.010 |
Why?
|
| Peer Review, Research | 1 | 2003 | 41 | 0.010 |
Why?
|
| Protein Isoforms | 1 | 2005 | 389 | 0.010 |
Why?
|
| Tissue Inhibitor of Metalloproteinases | 1 | 2003 | 17 | 0.010 |
Why?
|
| Reference Values | 1 | 2004 | 793 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2004 | 756 | 0.010 |
Why?
|
| Bias | 1 | 2003 | 196 | 0.010 |
Why?
|
| Nitric Oxide Synthase Type I | 1 | 2002 | 28 | 0.010 |
Why?
|
| Statistics as Topic | 1 | 2003 | 307 | 0.010 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2002 | 203 | 0.010 |
Why?
|
| DNA | 1 | 2008 | 1396 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2005 | 1584 | 0.010 |
Why?
|
| Surveys and Questionnaires | 1 | 2010 | 5384 | 0.010 |
Why?
|
| Colorado | 1 | 2003 | 4406 | 0.010 |
Why?
|
| Time Factors | 1 | 2003 | 6543 | 0.010 |
Why?
|